Skip directly to content

Save TBTC

TAG works to raise awareness among members of Congress about pressing issues that affect the United States’ critical TB programs. We work in coalition with other advocacy organizations and community advocates to effect policy change on the domestic and international fronts.

Save the TBTC

The Save the TBTC campaign aims to raise awareness about the TBTC’s important work, and to sustain and accelerate funding to ensure that it continues. In May 2013, TAG, the American Thoracic Society, and the Infectious Diseases Society of America sent a letter to the Subcommittee on Labor, Health and Human Services of the Senate Appropriations Committee expressing concern about the devastating impact of sequestration cuts on TB research and care, and requesting that TBTC funding be restored and preserved for FY2014 and beyond.

TheTuberculosis Trials Consortium (TBTC) plays an important role in linking innovative research with TB care and treatment. The TBTC is the leading TB clinical research collaborative in the world and, despite an already-insufficient budget, has conducted critical research that could spur the development of shorter, better-tolerated treatment regimens for curing and preventing the spread of TB. The TBTC has been a trailblazer in clinical research. Its efforts have lead to the discovery of a safe and efficacious regimen for drug-sensitive TB that allows treatment to be shortened from six months to just four months.

A shorter, safer, better-tolerated regimen will be transformative to TB care. Sequestration-related cuts are jeopardizing the launch of important late-stage clinical trials for a new treatment regimen. In collaboration with our partners, TAG will continue to work toward realizing the goal of zero TB infections and deaths globally.

See the links below for more about the TBTC and the projected effects of sequestration: